Biocon to invest 10% of biopharma revenues on R&D next fiscal
Continuing it emphasis on innovation, biotechnology major Biocon plans to spend 10 percent of its annual biopharma revenue on research and development in the next fiscal year.
Feb 01, 2015, 20:27 PM IST